Kaposi sarcoma (KS) was named for Dr. Moritz Kaposi who first described it in 1872. Kaposi's sarcoma (KS) was a rare form of relatively benign cancer that usually occured in older people who are of Mediterranean origin or cancer or transplant patients undergoing immunosuppressive therapy. Most KS cases have developed in association with human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS), especially among homosexual men. This is called AIDS-related Kaposi sarcoma. This disease typically causes tumors to develop in the tissues below the skin surface, or in the mucous membranes of the mouth, nose, or anus. These lesions (abnormal tissue areas) appear as raised blotches or lumps that may be purple, brown, or red. Sometimes the disease causes painful swelling, especially in the legs, groin area, or skin around the eyes. Extensive lung involvement by KS can be fatal. In 40% or more of patients with AIDS-associated Kaposi's sarcoma, the Kaposi lesions will shrink upon first starting highly active antiretroviral therapy (HAART).
Latest Publications and Research on AIDS/HIV - Common Opportunistic InfectionsTrends of HIV incidence and prevalence among men who have sex with men in Beijing, China: Nine consecutive cross-sectional surveys, 2008-2016. - Published by PubMed
Hepatitis C virus infection in children: How do we prevent it and how do we treat it? - Published by PubMed
Do HIV prevention interventions in Asia lead to increase in condom utilization?: A meta-analysis study. - Published by PubMed
Determinants of appropriate knowledge on human immunodeficiency virus postexposure prophylaxis among professional health-care workers in Sokoto, Nigeria. - Published by PubMed
A study on prevalence and correlates of depression among women living with human immunodeficiency virus/acquired immune deficiency syndrome in North Karnataka. - Published by PubMed